Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LENS trial of fenofibrate for non-proliferative diabetic retinopathy in Scotland
ISRCTN15073006Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Jul 2018
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in diabetic retinopathy (DR) comparing Fenofibrate with Placebo (2 arms). Primary endpoint: Composite progression or treatment endpoint. Started Jul 2018; status: completed.
02
Drugs
fenofibrate
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on ISRCTN15073006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15073006.